Company Quick10K Filing
Intersections
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-30
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-27
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-22
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-03-17
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-18
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-15
10-Q 2011-09-30 Filed 2011-11-09
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-10
10-K 2010-12-31 Filed 2011-03-16
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-12
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-16
8-K 2019-01-11
8-K 2018-11-28
8-K 2018-11-09
8-K 2018-10-31
8-K 2018-10-31
8-K 2018-09-25
8-K 2018-08-16
8-K 2018-06-27
8-K 2018-06-08
8-K 2018-05-30
8-K 2018-05-10
8-K 2018-04-03
8-K 2018-04-02
8-K 2018-02-28
8-K 2018-02-22
8-K 2018-02-20
8-K 2018-01-29

Intersections Financials

INTX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Axim Biotechnologies (AXIM) 45,833 18% -9.2 -211% 2,377 8,554 513 95 -5,011 -4,838 44,666
Hickok (HICKA) 45,489 22% 4.7 11% 62,836 43,919 89,731 19,505 6,620 10,751 50,895
PayMeOn (PAYM) 45,400 -1,762% -13.7 -131% 2,583 3,294 4 -69 -3,373 -3,295 45,135
Arch Therapeutics (ARTH) 45,130 -9.4 -157% 2,902 3,710 0 0 -4,548 -4,548 42,950
Positive Physicians Holdings (PPHI) 44,543 0% 148.2 -0% 154,581 81,735 20,883 0 -474 174 25,856
Intersections (INTX) 44,437 68% 4.2 25% 37,736 36,881 155,171 105,871 9,357 13,535 56,883
Petroshare (PRHR) 44,347 0% 5.6 -15% 36,928 45,101 16,134 0 -5,501 7,311 40,589
Medicine Man Technologies (MDCL) 44,094 40% -2.1 -38% 35,919 7,979 9,100 3,629 -13,562 -13,517 28,889
Terra Tech (TRTC) 44,034 50% -2.4 -23% 129,806 38,597 25,337 12,769 -29,554 -23,775 57,216
Hoth Therapeutics (HOTH) 44,012 -10.7 -88% 4,335 25 0 0 -3,793 -3,793 40,597
Cosmos Holdings (COSM) 43,856 7% 120.0 -1% 21,280 27,665 36,392 2,689 -183 380 45,596
Gulfslope Energy (GSPE) 43,691 -3.7 -45% 30,784 31,113 0 0 -13,724 -11,439 42,552
Solis Tek (SLTK) 43,678 51% -25.8 -163% 1,378 6,785 1,895 973 -2,244 -1,693 43,612
Where Food Comes From (WFCF) 43,107 42% 21.1 4% 19,538 6,989 15,075 6,341 759 1,882 39,712
CCUR (CCUR) 42,638 0% 7.9 6% 65,998 9,965 5,021 0 4,245 4,508 35,471
Smartag International (SMRN) 42,619 100% -140.1 -347% 87 31 1 1 -304 -304 42,532
Mastermind (MMND) 42,338 88% 91.3 16% 2,419 256 3,727 3,297 375 459 41,906
Newgioco (NWGI) 42,058 0% -17.6 -21% 25,358 17,927 25,127 0 -5,400 -2,117 37,352
Parallax Health Sciences (PRLX) 41,922 280% -5.4 -333% 2,373 7,209 82 229 -7,914 -7,871 42,507
Sanuwave Health (SNWV) 41,781 42% -5.8 -467% 1,644 14,962 693 290 -7,680 -7,149 41,378

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash19,61529,53230,83430,56221,19230,05825,55920,01520,61720,51620,92018,65012,41211,48911,32510,0779,5848,17811,47126,94920,31713,79710,8575,2309,5056,9702408,4377,6655,789
Accounts Receivable23,31822,03224,79025,16623,83625,74522,26528,41325,07024,74821,07018,07219,40516,08415,47915,06312,1588,6188,1639,10110,9619,2727,9727,9537,1596,4968,2256,0066,3216,147
Inventory3831,8731,9492,2532,1772,1334,0602502500
PP&E23,39923,64323,81822,64720,94319,81973,29515,94814,98513,99166,24314,16068,50169,65750,71351,54352,50544,58341,82343,48912,84913,99940,44910,45310,51910,43045,09010,5919,5948,509
Assets165,952172,194166,751161,131154,474159,524146,353144,320140,746134,551131,089126,704125,343125,977104,581103,25084,51580,93970,03084,98476,98568,52752,85747,22449,17944,23046,47942,07041,06337,736
Accounts Payable3,3655,5561,5262,0741,6363,0913,8897574,5863,6649552,8011,4701,9695,3564,8464,4894,4793,2074,3112,1332,4472,5364,2041,5362,9123,4982,4172,3662,746
Long-Term Debt1,8461,65620,00018,35617,10613,43220,00019,12919,18221,50020,79019,92918,235
Liabilities61,20366,25458,86449,76338,81339,82036,96839,23437,54934,97033,62636,09136,01640,04439,45437,31641,26241,33236,55254,84550,85048,23245,49044,00950,81247,85945,88541,38940,05436,881
Stockholders' Equity104,749105,940107,887111,368115,661119,704109,385105,086103,19799,58197,46390,61389,32785,93365,12765,93443,25339,60733,47830,13926,13520,2957,3673,215-1,633-3,6295946811,009855
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue94,08594,32894,14390,23287,91986,65384,38281,74180,76575,86872,08466,01164,31359,81456,55655,51251,96848,93947,40845,64844,75143,06242,20140,44939,93539,24839,98839,07838,62037,485
Cost of Revenue27,82929,30428,11626,21126,36427,14927,10527,17427,19726,65724,17522,23721,02223,60920,02617,79815,16016,03815,94914,69012,98413,72212,44213,00313,56913,12612,01612,38212,42112,481
Gross Profit66,25665,02466,02764,02161,55559,50457,27754,56753,56849,21147,90943,77443,29136,20536,53037,71436,80832,90131,45930,95831,76729,34029,75927,44626,36626,12227,97226,69626,19925,004
R&D2,100900
SG&A26,56527,42331,00825,49225,31124,67828,25026,27928,24827,19426,87927,01227,45227,62422,77323,92425,48625,32626,63121,71123,30523,61321,35320,45919,31017,91217,41514,04015,42114,669
Tax3,8182,9612,2744,2918,8343,7103,0062,6001,6201014333,951-1,294-5,850-7,043-47113,804-2,383-4,84872,390-133145-10-186-1,892-5230220
Net Income5,1854,6224,2346,2267,8065,6621,6102,2061,571-1,485120-2,784-2,035-3,906-21,969-1,224-24,840-4,328-14,096-4,266-5,307-8,108-12,787-4,802-6,182-4,3993,0771,7935,596-1,109
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating15,9398,07516,0828,64313,89210,3293,8258,3555,2285,6795,669-4,1471,1081,1901,413-139-2,733-479-3,554-2,7002,812-3,7732501,7041,6841,3801,0451,095
Cash Investing-331-2,774-1,795-3,373-1,205-1,388-1,530-2,022-1,368-1,434-2,448-1,532-1,838-1,924-1,179-962-975-1,878-1,075-2,305-1,351-1,628-1,316-1,350-2,093-1,137-623-505
Cash Financing-5,691-3,999-14,559-14,640-3,821-13,440-7,839-5,731-3,961-3,841-5,491-559-193-514-727-3057,00117,835-2,003-1,515-4,080-5475,341-5801,941-308-1,194